COVID-19 Vaccine: The Fight Against SARS-CoV-2 Infection
DOI:
https://doi.org/10.52253/vjta.2021.v02i01.04Keywords:
SARS-CoV-2, vaccine platforms, COVID-19 vaccineAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the pandemic in the year 2020, leading to disruption of the healthcare system with a great impact on socio-economy worldwide. Owing to this, an accelerated development of safe and efficient vaccines is required to fight against this virus. In this line, various vaccine development platforms have been exploited globally in order to manage the exponentially increasing rate of infection and mortality. Some vaccines in clinical phase trials have entered into emergency use authorization by few countries while others are in a preclinical stage. The present review summarizes the various platforms of vaccine development and also gives an insight into the vaccination programme initiated in India.
Downloads
Downloads
Published
Issue
Section
Share it
License
Copyright (c) 2021 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License which permits
its use, distribution and reproduction in any medium, provided the original work is cited.